159 related articles for article (PubMed ID: 36878711)
21. Early screening of nasopharyngeal carcinoma.
Yuan Y; Ye F; Wu JH; Fu XY; Huang ZX; Zhang T
Head Neck; 2023 Oct; 45(10):2700-2709. PubMed ID: 37552128
[TBL] [Abstract][Full Text] [Related]
22. Cell-free EBV DNA as a biomarker during clinical management of nasopharyngeal carcinoma in a nonendemic region.
Pramanik R; Arora S; Sharma P; Biswas A; Nayak B; Thakar A; Sharma A; Ghose S
J Med Virol; 2022 Feb; 94(2):720-728. PubMed ID: 34750844
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
[TBL] [Abstract][Full Text] [Related]
25. Combining Transoral Nasopharyngeal Brush and Plasma Epstein-Barr Virus DNA in Detecting Locally Recurrent Nasopharyngeal Carcinoma.
Lai R; Yeung DCM; Yeung ZWC; Hui TSC; Lam WKJ; Chan KCA; Ng CWK; To ZWH; Cho RHW; Chan CPL; Lai CCF; Leung NMW; Wong EWY; Chung JCK; Tsang RKY; Li KWS; Chow JCH; Cheung KKM; Chan JYK
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1208-1214. PubMed ID: 37232502
[TBL] [Abstract][Full Text] [Related]
26. Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus.
Vasudevan HN; Yom SS
Hematol Oncol Clin North Am; 2021 Oct; 35(5):963-971. PubMed ID: 34187713
[TBL] [Abstract][Full Text] [Related]
27. EBV DNA methylation profiles and its application in distinguishing nasopharyngeal carcinoma and nasal NK/T-cell lymphoma.
Tang CL; Li XZ; Zhou T; Deng CM; Jiang CT; Zhang YM; Liao Y; Wang TM; He YQ; Xue WQ; Jia WH; Zheng XH
Clin Epigenetics; 2024 Jan; 16(1):11. PubMed ID: 38212818
[TBL] [Abstract][Full Text] [Related]
28. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
29. The Role of Epstein-Barr Virus DNA Load and Serology as Screening Tools for Nasopharyngeal Carcinoma.
Tay JK; Chan SH; Lim CM; Siow CH; Goh HL; Loh KS
Otolaryngol Head Neck Surg; 2016 Aug; 155(2):274-80. PubMed ID: 27143706
[TBL] [Abstract][Full Text] [Related]
30. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
[TBL] [Abstract][Full Text] [Related]
31. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
Gao W; Wong TS; Lv KX; Zhang MJ; Tsang RK; Chan JY
Head Neck; 2019 Mar; 41(3):780-792. PubMed ID: 30548946
[TBL] [Abstract][Full Text] [Related]
32. Performance and Operational Feasibility of Epstein-Barr Virus-Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches.
Lou PJ; Jacky Lam WK; Hsu WL; Pfeiffer RM; Yu KJ; Chan CML; Lee VCT; Chen TC; Terng SD; Tsou YA; Leu YS; Liao LJ; Chang YL; Chien YC; Wang CP; Lin CY; Hua CH; Lee JC; Yang TL; Hsiao CH; Wu MS; Tsai MH; Cheng HC; Hildesheim A; Chen CJ; Chan KCA; Liu Z;
J Clin Oncol; 2023 Sep; 41(26):4257-4266. PubMed ID: 37478397
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
Coghill AE; Wang CP; Verkuijilen SAWM; Yu KJ; Hsu WL; Middeldorp JM; Hildesheim A
J Med Virol; 2018 Jan; 90(1):191-195. PubMed ID: 28833336
[TBL] [Abstract][Full Text] [Related]
34. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.].
Senyuta NB; Smirnova KV; Kondratova VN; Ignatova AV; Mudunov AM; Dushenkina TE; Liechtenstein AV; Gurtsevich VE
Vopr Virusol; 2019; 64(5):229-237. PubMed ID: 32167688
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
[TBL] [Abstract][Full Text] [Related]
37. Development of a non-invasive method, multiplex methylation specific PCR (MMSP), for early diagnosis of nasopharyngeal carcinoma.
Zhang Z; Sun D; Hutajulu SH; Nawaz I; Nguyen Van D; Huang G; Haryana SM; Middeldorp JM; Ernberg I; Hu LF
PLoS One; 2012; 7(11):e45908. PubMed ID: 23144779
[TBL] [Abstract][Full Text] [Related]
38. Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area.
Taverna F; Alfieri S; Romanò R; Campanini G; Marceglia S; Giardina F; Mazzocchi A; Comoli P; Gloghini A; Quattrone P; Bergamini C; Apollonio G; Filippini DM; Orlandi E; Locati LD; Licitra L; Baldanti F; Bossi P
Oral Oncol; 2022 Dec; 135():106229. PubMed ID: 36347145
[TBL] [Abstract][Full Text] [Related]
39. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
[TBL] [Abstract][Full Text] [Related]
40. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
Tan LP; Tan GW; Sivanesan VM; Goh SL; Ng XJ; Lim CS; Kim WR; Mohidin TBBM; Mohd Dali NS; Ong SH; Wong CY; Sawali H; Yap YY; Hassan F; Pua KC; Koay CE; Ng CC; Khoo AS;
Int J Cancer; 2020 Apr; 146(8):2336-2347. PubMed ID: 31469434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
